These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29564992)

  • 1. The neuropathological study of myelin oligodendrocyte glycoprotein in the temporal lobe of schizophrenia patients.
    Marui T; Torii Y; Iritani S; Sekiguchi H; Habuchi C; Fujishiro H; Oshima K; Niizato K; Hayashida S; Masaki K; Kira J; Ozaki N
    Acta Neuropsychiatr; 2018 Aug; 30(4):232-240. PubMed ID: 29564992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aging on the morphologies of Heschl's gyrus and the superior temporal gyrus in schizophrenia: a postmortem study.
    Torii Y; Iritani S; Sekiguchi H; Habuchi C; Hagikura M; Arai T; Ikeda K; Akiyama H; Ozaki N
    Schizophr Res; 2012 Feb; 134(2-3):137-42. PubMed ID: 22115995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia.
    Haroutunian V; Katsel P; Dracheva S; Stewart DG; Davis KL
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):565-73. PubMed ID: 17291370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia.
    Kunii Y; Yabe H; Wada A; Yang Q; Nishiura K; Niwa S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1139-43. PubMed ID: 21453742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrocyte pathophysiology: a new view of schizophrenia.
    Segal D; Koschnick JR; Slegers LH; Hof PR
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):503-11. PubMed ID: 17291369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.
    Takahashi N; Sakurai T; Davis KL; Buxbaum JD
    Prog Neurobiol; 2011 Jan; 93(1):13-24. PubMed ID: 20950668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia.
    Haroutunian V; Davis KL
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):499-502. PubMed ID: 17583597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin/oligodendrocyte glycoprotein expression during development in normal and myelin-deficient mice.
    Matthieu JM; Amiguet P
    Dev Neurosci; 1990; 12(4-5):293-302. PubMed ID: 2289413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin Oligodendrocyte Glycoprotein and Multiple Sclerosis.
    Androutsou ME; Tapeinou A; Vlamis-Gardikas A; Tselios T
    Med Chem; 2018 Feb; 14(2):120-128. PubMed ID: 28875859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
    Tkachev D; Mimmack ML; Ryan MM; Wayland M; Freeman T; Jones PB; Starkey M; Webster MJ; Yolken RH; Bahn S
    Lancet; 2003 Sep; 362(9386):798-805. PubMed ID: 13678875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder.
    Chambers JS; Perrone-Bizzozero NI
    Neurochem Res; 2004 Dec; 29(12):2293-302. PubMed ID: 15672553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.
    Crang AJ; Gilson JM; Li WW; Blakemore WF
    Eur J Neurosci; 2004 Sep; 20(6):1445-60. PubMed ID: 15355312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.
    Saia-Cereda VM; Cassoli JS; Schmitt A; Falkai P; Nascimento JM; Martins-de-Souza D
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):601-12. PubMed ID: 26232077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.
    Stewart DG; Davis KL
    Int Rev Neurobiol; 2004; 59():381-424. PubMed ID: 15006496
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of Oct-6, a POU III domain transcription factor, in schizophrenia.
    Ilia M; Beasley C; Meijer D; Kerwin R; Cotter D; Everall I; Price J
    Am J Psychiatry; 2002 Jul; 159(7):1174-82. PubMed ID: 12091196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study.
    Katsel P; Davis KL; Haroutunian V
    Schizophr Res; 2005 Nov; 79(2-3):157-73. PubMed ID: 16139990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia--a postmortem study.
    Kang K; Huang XF; Wang Q; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):867-71. PubMed ID: 19389456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.
    Duignan S; Wright S; Rossor T; Cazabon J; Gilmour K; Ciccarelli O; Wassmer E; Lim M; Hemingway C; Hacohen Y
    Dev Med Child Neurol; 2018 Sep; 60(9):958-962. PubMed ID: 29468668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gene expression in the superior temporal gyrus in schizophrenia.
    Bowden NA; Scott RJ; Tooney PA
    BMC Genomics; 2008 Apr; 9():199. PubMed ID: 18445270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?
    Keshavan MS; Haas GL; Kahn CE; Aguilar E; Dick EL; Schooler NR; Sweeney JA; Pettegrew JW
    J Psychiatr Res; 1998; 32(3-4):161-7. PubMed ID: 9793869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.